These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 16627341

  • 1. The apoptotic and proliferative fate of cytokine-induced killer cells after redirection to tumor cells with bispecific Ab.
    Kornacker M, Verneris M, Kornacker B, Ganten T, Scheffold C, Negrin R.
    Cytotherapy; 2006; 8(1):13-23. PubMed ID: 16627341
    [Abstract] [Full Text] [Related]

  • 2. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study.
    Chan JK, Hamilton CA, Cheung MK, Karimi M, Baker J, Gall JM, Schulz S, Thorne SH, Teng NN, Contag CH, Lum LG, Negrin RS.
    Clin Cancer Res; 2006 Mar 15; 12(6):1859-67. PubMed ID: 16551871
    [Abstract] [Full Text] [Related]

  • 3. Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3.
    Scheffold C, Kornacker M, Scheffold YC, Contag CH, Negrin RS.
    Cancer Res; 2002 Oct 15; 62(20):5785-91. PubMed ID: 12384539
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of an automated closed fluid management device for processing expanded cytokine-induced killer cells to use in immunotherapy programs for cancer.
    Giancola R, Olioso P, Di Riti M, Capone A, Contento A, Pompetti F, Iacone A.
    Transfusion; 2008 Apr 15; 48(4):629-39. PubMed ID: 18208417
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.
    Schmidt-Wolf IG, Lefterova P, Mehta BA, Fernandez LP, Huhn D, Blume KG, Weissman IL, Negrin RS.
    Exp Hematol; 1993 Dec 15; 21(13):1673-9. PubMed ID: 7694868
    [Abstract] [Full Text] [Related]

  • 6. Preclinical studies comparing different bispecific antibodies for redirecting T cell cytotoxicity to extracellular antigens on prostate carcinomas.
    Lum HE, Miller M, Davol PA, Grabert RC, Davis JB, Lum LG.
    Anticancer Res; 2005 Dec 15; 25(1A):43-52. PubMed ID: 15816517
    [Abstract] [Full Text] [Related]

  • 7. Effects of Ganoderma lucidum polysaccharides on proliferation and cytotoxicity of cytokine-induced killer cells.
    Zhu XL, Lin ZB.
    Acta Pharmacol Sin; 2005 Sep 15; 26(9):1130-7. PubMed ID: 16115382
    [Abstract] [Full Text] [Related]

  • 8. [Coculture of dendritic cell with cytokine-induced killer results in a significant increase in cytotoxic activity of CIK to tumor cells in vitro and in vivo].
    Ge W, Li CH, Zhang W, Han Q, Deng WM, Chen L, You SG, Zhao CH.
    Zhonghua Xue Ye Xue Za Zhi; 2004 May 15; 25(5):277-80. PubMed ID: 15182535
    [Abstract] [Full Text] [Related]

  • 9. Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells.
    Keler T, Graziano RF, Mandal A, Wallace PK, Fisher J, Guyre PM, Fanger MW, Deo YM.
    Cancer Res; 1997 Sep 15; 57(18):4008-14. PubMed ID: 9307286
    [Abstract] [Full Text] [Related]

  • 10. [Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].
    Li H, Ren XB, Zhang P, An XM, Liu H, Hao XS.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 23; 85(44):3134-8. PubMed ID: 16405818
    [Abstract] [Full Text] [Related]

  • 11. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G, Gückel B, Wallwiener D, Moldenhauer G.
    Clin Cancer Res; 1999 Jan 23; 5(1):171-80. PubMed ID: 9918216
    [Abstract] [Full Text] [Related]

  • 12. Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene.
    Finke S, Trojaneck B, Lefterova P, Csipai M, Wagner E, Kircheis R, Neubauer A, Huhn D, Wittig B, Schmidt-Wolf IG.
    Gene Ther; 1998 Jan 23; 5(1):31-9. PubMed ID: 9536262
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-zeta activating signal.
    Marin V, Kakuda H, Dander E, Imai C, Campana D, Biondi A, D'Amico G.
    Exp Hematol; 2007 Sep 23; 35(9):1388-97. PubMed ID: 17656004
    [Abstract] [Full Text] [Related]

  • 14. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
    Franceschetti M, Pievani A, Borleri G, Vago L, Fleischhauer K, Golay J, Introna M.
    Exp Hematol; 2009 May 23; 37(5):616-628.e2. PubMed ID: 19375652
    [Abstract] [Full Text] [Related]

  • 15. Redirected T-cell cytotoxicity to epithelial cell adhesion molecule-overexpressing adenocarcinomas by a novel recombinant antibody, E3Bi, in vitro and in an animal model.
    Ren-Heidenreich L, Davol PA, Kouttab NM, Elfenbein GJ, Lum LG.
    Cancer; 2004 Mar 01; 100(5):1095-103. PubMed ID: 14983507
    [Abstract] [Full Text] [Related]

  • 16. Anti-CD3 x anti-tumor F(ab')2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes.
    Chapoval AI, Nelson H, Thibault C.
    J Immunol; 1995 Aug 01; 155(3):1296-303. PubMed ID: 7636196
    [Abstract] [Full Text] [Related]

  • 17. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
    Zhou J, Chen J, Zhong R, Mokotoff M, Shultz LD, Ball ED.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2224-31. PubMed ID: 16609038
    [Abstract] [Full Text] [Related]

  • 18. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
    Klöss S, Bochennek K, Huenecke S, Zimmermann SY, Kuçi S, Müller T, Wels WS, Klingebiel T, Esser R, Koehl U.
    J Immunol Methods; 2007 Aug 31; 325(1-2):140-7. PubMed ID: 17663991
    [Abstract] [Full Text] [Related]

  • 19. Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma.
    Kim HM, Lim J, Yoon YD, Ahn JM, Kang JS, Lee K, Park SK, Jeong YJ, Kim JM, Han G, Yang KH, Kim YJ, Kim Y, Han SB.
    Int Immunopharmacol; 2007 Dec 15; 7(13):1793-801. PubMed ID: 17996690
    [Abstract] [Full Text] [Related]

  • 20. Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells.
    Verneris MR, Arshi A, Edinger M, Kornacker M, Natkunam Y, Karimi M, Cao YA, Marina N, Contag CH, Negrin RS.
    Clin Cancer Res; 2005 Jun 15; 11(12):4561-70. PubMed ID: 15958642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.